Study Identifies Altered Lipid Metabolism in Newborns with Gastroschisis
A new preprint study found that newborns with gastroschisis — a congenital abdominal wall defect — show distinct cord blood metabolic profiles compared to healthy controls, with 75% of the 53 differentially abundant metabolites being lipids. Despite a 97% surgical repair success rate, 40% of affected infants face readmission due to gastrointestinal complications whose biological basis has been poorly understood. These findings may help explain the condition's pathophysiology and point toward potential biomarkers for predicting or monitoring complications.
Researchers analyzed cord blood plasma from 23 neonates with gastroschisis and 23 healthy controls using ultra-performance liquid chromatography coupled with tandem mass spectrometry. Unsupervised statistical analyses, including principal component analysis and hierarchical clustering, showed clear separation between the two groups (PERMANOVA pseudo-F = 4.632, R² = 0.095, p = 0.001). Of the 53 metabolites identified as differentially abundant, approximately 75% were lipids. Specific alterations included reduced free fatty acids, elevated fatty acid amides and ceramides, disrupted steroid and bile acid metabolism, and decreased levels of biliverdin and bilirubin isomers. Gastroschisis affects roughly 1 in 2,000 births and involves herniation of fetal intestines into the amniotic cavity, where prolonged exposure to amniotic fluid is thought to damage intestinal tissue. The authors suggest these metabolic signatures may reflect underlying physiological stress relevant to post-surgical gastrointestinal complications. The study positions these metabolites as candidate biomarkers warranting further clinical investigation.
What's missing
As a preprint, this study has not yet undergone peer review. The relatively small sample size (23 per group) limits statistical power and generalizability.
What different sources said
- bioRxivCenter
Untargeted cord blood metabolomics reveals altered lipid metabolism in neonates with gastroschisis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.